Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 20 of 20 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD Technologies and Innovation develops technologies for parenteral drug delivery, advanced diagnostics, smart medical devices and genomic research and supports external innovation. The RTP site is BD's corporate technology R&D and innovation center. | Location Research Triangle Park |
| |
Company BioAesthetics Corporation | Activity: Research and Development | Company Description BioAesthetics Corporation is developing biomaterials, including the NACgraft, a nipple areolar complex graft to be used in regenerating the nipple-areolar complex for mastectomy patients. | Location Durham |
| |
Company Biocomposites Inc. | Activity: Sales and Operations | Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. | Location Wilmington |
| |
Company Caeregen Therapeutics LLC | Activity: Research and Development | Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. | Location Chapel Hill |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Research Triangle Park |
| |
Company CoImmune Inc. | Activity: Production and Manufacturing | Company Description CoImmune is an immuno-oncology company developing two cellular platform technologies. The CAR-CIK technology is a variation on CAR-T therapy being developed for liquid tumors and the RNA-loaded dendritic cell technology is being developed for solid tumors. | Location Durham |
| |
Company Enzyvant Inc. (Cary) | Activity: Research and Development | Company Description Enzyvant, a subsidiary of Sumitovant Biopharma, develops regenerative therapeutics for rare diseases such as congenital athymia. The Cary location is their headquarters. | Location Cary |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem |
| |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham |
| |
Company KeraNetics LLC | Activity: Research and Development | Company Description KeraNetics develops keratin-based biomaterials to be used for wound care and tissue regeneration. | Location Winston-Salem |
| |
Company LifeNet Health | Activity: Research and Development | Company Description LifeNet Health provides transplant solutions, including cellular therapy research, organ procurement and bio-implant. The North Carolina facility isolates liver cells and adult stem cells for applications in drug discovery and toxicity testing. | Location Research Triangle Park |
| |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park |
| |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem |
| |
Company Novex Innovations LLC | Activity: Production and Manufacturing | Company Description Novex Innovations is a contract development and manufacturing organization (CDMO) supporting large, medium, small and startup life science companies in the development of their products, from concept through manufacturing and commercialization. | Location Winston-Salem |
| |
Company Plakous Therapeutics LLC | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem |
| |
Company Precise Bio Inc. | Activity: Research and Development | Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. | Location Winston-Salem |
| |
Company ProKidney | Activity: Production and Manufacturing | Company Description ProKidney manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs. | Location Winston-Salem |
| |
Company SIF Biopharma LLC | Activity: Research and Development | Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. | Location Chapel Hill |
| |
Company United Therapeutics Corp. | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park |